A Comparison of Optive in Patients Previously Using Systane for the Treatment of Dry Eye

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate the effectiveness of NGT (Optive) vs. Systane Tears for patients with moderate to severe dry eye disease.

• Phase: Phase 4

Details

• Lead Sponsor: Innovative Medical

Criteria

Inclusion Criteria:

• · Dry eye disease diagnosis

• Patients must currently be using Systane tears at least once a day and for at least 1 month.

• Normal lid position and closure

• Male or female of legal age of consent

• Informed consent has been obtained

• Likely to complete all required follow-up visits

Exclusion Criteria:

• · Concurrent enrollment in an investigational drug or device study, or participation in such a study within 30 days of entry into this study.

• Subject has a condition, or is in a situation which, in the investigator's opinion, may put the subject at a significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study.